
671. Why Has There Been So Little Progress on Alzheimer’s Disease?
Freakonomics Radio
00:00
Cassava collapses under scrutiny
Stephen J. Dubner recounts findings against Hao Yan Wang and Cassava Sciences, including SEC penalties, failed trials, and the drug’s abandonment.
Play episode from 33:02
Transcript


